New study shows aspirin reduces risk of cancer

A new study has shown that taking aspirin regularly can significantly reduce the risk of cancer, in line with several earlier studies.

The researchers said that people who take aspirin regularly have a lower risk of cancer, particularly involving the colon and gastrointestinal tract. The study by researchers at the Massachusetts General Hospital suggests that aspirin use can complementestablished preventive screening measures such as colonoscopies but should not replace the existing measures.The researchers studied 32 years worth of data from nearly 136,000 nurses and health professionals through health surveys.

Senior author Andrew Chan of the Massachusetts General Hospital said, "We now can recommend that many individuals consider taking aspirin to reduce their risk of colorectal cancer - particularly those with other reasons for regular use, such as heart disease prevention."

Chan also said that the findings show that the use of the drug can prevent a significant number of colorectal cancers above and beyond those prevented by screening. It can also be useful where resources to devote to cancer screening are lacking. Several earlier studies have shown that regular aspirin use can help prevent colorectal cancer. The researchers studied 32 years worth of data from nearly 136,000 nurses and health professionals who answered health surveys.

The findings were published in the Journal of the American Medical Association (Jama) Oncology.

 

Region: 

Advertisements